| 1 |
Ding X, Zhong X, Yang Y, Zhang G, Si H. Citric Acid and Magnolol Ameliorate Clostridium perfringens Challenge in Broiler Chickens. Animals (Basel) 2023;13. [PMID: 36830364 DOI: 10.3390/ani13040577] [Reference Citation Analysis]
|
| 2 |
Azpilcueta-Nicolas CR, Meng D, Edelmann S, Lumb JP. Dearomatization of Biaryls through Polarity Mismatched Radical Spirocyclization. Angew Chem Int Ed Engl 2023;62:e202215422. [PMID: 36454656 DOI: 10.1002/anie.202215422] [Reference Citation Analysis]
|
| 3 |
Sanghavi KN, Kapadiya KM, Sriram D, Kumari J. Regioselective Pd-Catalyzed Suzuki–Miyaura Borylation Reaction for the Dimerization Product of 6-Bromoimidazo[1,2-a]pyridine-2-carboxylate: Mechanistic Pathway, Cytotoxic and Tubercular Studies. Synlett 2023. [DOI: 10.1055/s-0042-1751404] [Reference Citation Analysis]
|
| 4 |
Li Z, Hu S, Pu LY, Li Z, Zhu G, Cao Y, Li L, Ma Y, Liu Z, Li X, Liu G, Chen K, Wu Z. Design, synthesis and biological evaluation of a novel colchicine-magnolol hybrid for inhibiting the growth of Lewis lung carcinoma in Vitro and in Vivo. Front Chem 2022;10:1094019. [PMID: 36583151 DOI: 10.3389/fchem.2022.1094019] [Reference Citation Analysis]
|
| 5 |
Wang X, Liu Q, Fu Y, Ding R, Qi X, Zhou X, Sun Z, Bao J. Magnolol as a Potential Anticancer Agent: A Proposed Mechanistic Insight. Molecules 2022;27:6441. [DOI: 10.3390/molecules27196441] [Reference Citation Analysis]
|
| 6 |
Xie Y, Hua H, Zhou P. Magnolol as a potent antifungal agent inhibits Candida albicans virulence factors via the PKC and Cek1 MAPK signaling pathways. Front Cell Infect Microbiol 2022;12:935322. [DOI: 10.3389/fcimb.2022.935322] [Reference Citation Analysis]
|
| 7 |
Jiang XY, Ren ZY, Zhang NK, Yang KC, Wang GX, Jiang HF. Screening and evaluating honokiol from Magnolia officinalis against Nocardia seriolae infection in largemouth bass (Micropterus Salmoides). J Fish Dis 2022. [PMID: 35801398 DOI: 10.1111/jfd.13683] [Reference Citation Analysis]
|
| 8 |
Yu L, Hong W, Lu S, Li Y, Guan Y, Weng X, Feng Z. The NLRP3 Inflammasome in Non-Alcoholic Fatty Liver Disease and Steatohepatitis: Therapeutic Targets and Treatment. Front Pharmacol 2022;13:780496. [PMID: 35350750 DOI: 10.3389/fphar.2022.780496] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 9 |
Liu Y, Zhu T, Li J, Bao Y, Cheng B, Chen S, Du J, Hu S. Magnolol Hybrid Nanofibrous Mat with Antibacterial, Anti-Inflammatory, and Microvascularized Properties for Wound Treatment. Biomacromolecules. [DOI: 10.1021/acs.biomac.1c01430] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 10 |
Lim CL, Raju CS, Mahboob T, Kayesth S, Gupta KK, Jain GK, Dhobi M, Nawaz M, Wilairatana P, de Lourdes Pereira M, Patra JK, Paul AK, Rahmatullah M, Nissapatorn V. Precision and Advanced Nano-Phytopharmaceuticals for Therapeutic Applications. Nanomaterials (Basel) 2022;12:238. [PMID: 35055257 DOI: 10.3390/nano12020238] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 11 |
Cicalău GIP, (Groza) FM, Mandal AK, Ganea M, Scrobota I, Ciavoi G, Jurca CM. Formulation and Characterization of Hydrophilic Ointment Bases with Carvacrol and Magnolol for Periodontal Application. Pharmacophore 2022;13:26-32. [DOI: 10.51847/a7vnt1hx00] [Reference Citation Analysis]
|
| 12 |
Park H, Cho M, Do Y, Park JK, Bae SJ, Joo J, Ha KT. Autophagy as a Therapeutic Target of Natural Products Enhancing Embryo Implantation. Pharmaceuticals (Basel) 2021;15:53. [PMID: 35056110 DOI: 10.3390/ph15010053] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 13 |
Trifan A, Bostănaru AC, Luca SV, Temml V, Akram M, Herdlinger S, Kulinowski Ł, Skalicka-Woźniak K, Granica S, Czerwińska ME, Kruk A, Greige-Gerges H, Mareș M, Schuster D. Honokiol and Magnolol: Insights into Their Antidermatophytic Effects. Plants (Basel) 2021;10:2522. [PMID: 34834886 DOI: 10.3390/plants10112522] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 14 |
Fu M, Luo F, Wang E, Jiang Y, Liu S, Peng J, Liu B. Magnolol Attenuates Right Ventricular Hypertrophy and Fibrosis in Hypoxia-Induced Pulmonary Arterial Hypertensive Rats Through Inhibition of the JAK2/STAT3 Signaling Pathway. Front Pharmacol 2021;12:755077. [PMID: 34764873 DOI: 10.3389/fphar.2021.755077] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 15 |
Zhu G, Fang Y, Cui X, Jia R, Kang X, Zhao R. Magnolol upregulates CHRM1 to attenuate Amyloid-β-triggered neuronal injury through regulating the cAMP/PKA/CREB pathway. J Nat Med 2021. [PMID: 34705126 DOI: 10.1007/s11418-021-01574-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 16 |
Han J, Li L, Su M, Heng W, Wei Y, Gao Y, Qian S. Deaggregation and Crystallization Inhibition by Small Amount of Polymer Addition for a Co-Amorphous Curcumin-Magnolol System. Pharmaceutics 2021;13:1725. [PMID: 34684018 DOI: 10.3390/pharmaceutics13101725] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 17 |
Szałabska-Rąpała K, Borymska W, Kaczmarczyk-Sedlak I. Effectiveness of Magnolol, a Lignan from Magnolia Bark, in Diabetes, Its Complications and Comorbidities-A Review. Int J Mol Sci 2021;22:10050. [PMID: 34576213 DOI: 10.3390/ijms221810050] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 18 |
Nikawa T, Ulla A, Sakakibara I. Polyphenols and Their Effects on Muscle Atrophy and Muscle Health. Molecules 2021;26:4887. [PMID: 34443483 DOI: 10.3390/molecules26164887] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 7.0] [Reference Citation Analysis]
|
